Disorders of sex development in Wolf–Hirschhorn syndrome: a genotype–phenotype correlation and MSX1 as candidate gene
Tóm tắt
Wolf–Hirschhorn (WHS) is a set of congenital physical anomalies and mental retardation associated with a partial deletion of the short arm of chromosome 4. To establish a genotype–phenotype correlation; we carried out a molecular cytogenetic analysis on two Tunisian WHS patients. Patient 1 was a boy of 1-year-old, presented a typical WHS phenotype while patient 2, is a boy of 2 days presented an hypospadias, a micropenis and a cryptorchidie in addition to the typical WHS phenotype. Both the array comparative genomic hybridization and fluorescence in situ hybridization techniques were used. Results of the analysis showed that patient 2 had a greater deletion size (4.8 Mb) of chromosome 4 than patient 1 (3.4 Mb). Here, we notice that the larger the deletion, the more genes are likely to be involved, and the more severe the phenotype is likely to be. If we analyze the uncommon deleted region between patient1 and patient 2 we found that the Muscle Segment Homeobox (MSX1) gene is included in this region. MSX1 is a critical transcriptional repressor factor, expressed in the ventral side of the developing anterior pituitary and implicated in gonadotrope differentiation. Msx1 acts as a negative regulatory pituitary development by repressing the gonadotropin releasing hormone (GnRH) genes during embryogenesis. We hypothesized that the deletion of MSX1 in our patient may deregulate the androgen synthesis. Based on the MSX1 gene function, its absence might be indirectly responsible for the hypospadias phenotype by contributing to the spatiotemporal regulation of GnRH transcription during development.
Tài liệu tham khảo
Battaglia A, Carey JC, South ST. Wolf–Hirschhorn syndrome: a review and update. Am J Med Genet Part C Semin Med Genet. 2015;169:216–23.
Andrieux J, et al. Genotype-phenotype correlation in 21 patients with Wolf–Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH). J Med Genet. 2007;45:71–80.
Battaglia A, Carey JC. Wolf–Hirschhorn syndrome and the 4p-related syndromes. Am J Med Genet Part C Semin Med Genet. 2008;148C:241–3.
Van Buggenhout G, et al. Mild Wolf–Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet. 2004;41:691–8.
Zampino G, et al. Genotype-phenotype correlations and clinical diagnostic criteria in Wolf–Hirschhorn syndrome. Am J Med Genet. 2002;94:254–61.
Wright TJ, et al. A transcript map of the newly defined 165 kb Wolf–Hirschhorn syndrome critical region. Hum Mol Genet. 1997;6:317–24.
Zollino M, et al. Mapping the Wolf–Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am J Hum Genet. 2003;1:590–7.
Kook H, et al. Multiple myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity. Mol Cell Biol. 2008;28:2023–34.
Zhou M-M, et al. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood. 2007;111:3145–54.
Stec I, et al. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf–Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet. 1998;7:1071–82.
Cappuccio G, et al. A case of 14q11.2 microdeletion with autistic features, severe obesity and facial dysmorphisms suggestive of Wolf–Hirschhorn syndrome. Am J Med Genet Part A. 2013;164:190–3.
Hajdu I, Ciccia A, Lewis SM, Elledge SJ. Wolf–Hirschhorn syndrome candidate 1 is involved in the cellular response to DNA damage. Proc Natl Acad Sci. 2011;108:13130–4.
Kratsios P, et al. Multiple congenital malformations of Wolf–Hirschhorn syndrome are recapitulated in Fgfrl1 null mice. Dis Model Mech. 2009;2:283–94.
Engbers H, et al. Wolf–Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions. Eur J Hum Genet. 2009;17:129–32.
Endele S, Fuhry M, Pak SJ, Zabel BU, Winterpacht A. LETM1, a novel gene encoding a putative EF-hand Ca2+-binding protein, flanks the Wolf–Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics. 1999;60:218–25.
Burgess DL, Jones JM, Meisler MH, Noebels JL. Mutation of the Ca2+channel β subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell. 1997;88:385–92.
Schlickum S, et al. LETM1, a gene deleted in Wolf–Hirschhorn syndrome, encodes an evolutionarily conserved mitochondrial protein. Genomics. 2004;83:254–61.
Dimmer KS, et al. LETM1, deleted in Wolf–Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability. Hum Mol Genet. 2008;17:201–14.
McQuibban AG, et al. A Drosophila mutant of LETM1, a candidate gene for seizures in Wolf–Hirschhorn syndrome. Hum Mol Genet. 2010;19:987–1000.
Misceo D, et al. 1.5Mb deletion of chromosome 4p16.3 associated with postnatal growth delay, psychomotor impairment, epilepsy, impulsive behavior and asynchronous skeletal development. Gene. 2012;507:85–91.
Limongelli I, et al. Dravet phenotype in a subject with a der(4)t(4;8)(p16.3;p23.3) without the involvement of the LETM1 gene. Eur J Med Genet. 2013;56:551–5.
Narita T, et al. NELF interacts with CBC and participates in 3′ end processing of replication-dependent histone mRNAs. Mol Cell. 2007;26:349–65.
Sun J, Li R. Human negative elongation factor activates transcription and regulates alternative transcription initiation. J Biol Chem. 2010;285:6443–52.
Chiba K, Yamamoto J, Yamaguchi Y, Handa H. Promoter-proximal pausing and its release: molecular mechanisms and physiological functions. Exp Cell Res. 2010;316:2723–30.
Colnaghi R, et al. Characterizing the functional consequences of haploinsufficiency of NELF-A (WHSC2) and SLBP identifies novel cellular phenotypes in Wolf–Hirschhorn syndrome. Hum Mol Genet. 2012;21:2181–93.
Schlickum S, Winterpacht A, Endele S, Bördlein A, Nelkenbrecher C. C4ORF48, a gene from the Wolf–Hirschhorn syndrome critical region, encodes a putative neuropeptide and is expressed during neocortex and cerebellar development. Neurogenetics. 2011;12:155–63.
Zhang H, Catron KM, Abate-Shen C. A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression. Proc Natl Acad Sci. 2002;93:1764–9.
Bendall AJ, Bendall CA-S. 2000 Roles for Msx and Dlx homeoproteins…pdf. Gene. 2000;247:17–31.
Nieminen P, et al. MSX1 gene is deleted in Wolf–Hirschhorn syndrome patients with oligodontia. J Dent Res. 2003;82:1013–7.
Scully KM, Rosenf MG. Pituitary Development: regulatory codes in mammalian organogenesis. Science (80–). 2010;2231:2231–5.
MacKenzie A, Ferguson MW, Sharpe PT. Hox-7 expression during murine craniofacial development. Development. 1991;113:601–11.
Mellon PL, et al. Developmental regulation of gonadotropin-releasing hormone gene expression by the MSX and DLX homeodomain protein families. J Biol Chem. 2005;280:19156–65.
Wu TJ, Gibson MJ, Silverman AJ. Gonadotropin-releasing hormone (GnRH) neurons of the developing tectum of the mouse. J Neuroendoocrinol. 1995;7:899–902.
Guimaraes L, et al. New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism. Eur Soc Endocrinol. 2019. https://doi.org/10.1530/EJE-18-0764
Liang J, et al. MSX1 mutations and associated disease phenotypes: genotype-phenotype relations. Eur J Hum Genet. 2016. https://doi.org/10.1038/ejhg.2016.78.
Ye CJ, Stilgenbauer L, Moy A, Liu G, Heng HH. What is karyotype coding and why is genomic topology important for cancer and evolution? Front Genet. 2019;10:1–8.
Flipsen-ten Berg K, et al. Unmasking of a hemizygous WFS1 gene mutation by a chromosome 4p deletion of 8.3 Mb in a patient with Wolf-Hirschhorn syndrome. Eur J Hum Genet. 2007;15:1132–8.
Chen CP, et al. Wolf-Hirschhorn (4p-) syndrome: prenatal diagnosis, molecular cytogenetic characterization and association with a 1.2-Mb microduplication at 8p22-p21.3 and a 1.1-Mb microduplication at 10p15.3 in a fetus with an apparently pure 4p deletion. Taiwan J Obstet Gynecol. 2011;50:506–11.
Sifakis S, et al. Prenatal diagnosis of Wolf-Hirschhorn syndrome confirmed by comparative genomic hybridization array: report of two cases and review of the literature. Mol Cytogenet. 2012;5:1–7.
Malvestiti F, et al. Recombinant chromosome 4 from a familial pericentric inversion: prenatal and adulthood Wolf-Hirschhorn phenotypes. Case Rep Genet. 2013;2013:1–4.
Venegas-Vega CA, Fernández-Ramírez F, Zepeda LM, Nieto-Martínez K, Gómez-Laguna L, Garduño-Zarazúa LM, Berumen J, Kofman S, Cervantes A. Diagnosis of familial Wolf-Hirschhorn syndrome due to a paternal cryptic chromosomal rearrangement by conventional and molecular cytogenetic techniques. BioMed Res Int. 2013;2013:1–8.